Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
70
INVA Quote, Financials, Valuation and Earnings
Last price:
$23.62
Seasonality move
:
1.25%
Day range:
$23.35 - $23.86
52-week range:
$16.52 - $24.01
Dividend yield:
0%
P/E ratio:
16.97x
P/S ratio:
4.65x
P/B ratio:
1.75x
Volume:
685.1K
Avg. volume:
745.4K
1-year change:
31.23%
Market cap:
$1.8B
Revenue:
$372.5M
EPS (TTM):
$1.39
Analysts' Opinion
-
Consensus RatingInnoviva, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 0 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $33.00, Innoviva, Inc. has an estimated upside of 39.48% from its current price of $23.66.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $18.00 representing 23.92% downside risk from its current price of $23.66.
Fair Value
-
According to the consensus of 5 analysts, Innoviva, Inc. has 39.48% upside to fair value with a price target of $33.00 per share.
INVA vs. S&P 500
-
Over the past 5 trading days, Innoviva, Inc. has overperformed the S&P 500 by 7.62% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Innoviva, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Innoviva, Inc. has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Innoviva, Inc. reported revenues of $111.3M.
Earnings Growth
-
Innoviva, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Innoviva, Inc. reported earnings per share of $1.08.
Enterprise value:
1.5B
EV / Invested capital:
--
Price / LTM sales:
4.65x
EV / EBIT:
8.90x
EV / Revenue:
3.72x
PEG ratio (5yr expected):
0.17x
EV / Free cash flow:
7.61x
Price / Operating cash flow:
9.52x
Enterprise value / EBITDA:
7.19x
Gross Profit (TTM):
$310M
Return On Assets:
9.67%
Net Income Margin (TTM):
31.65%
Return On Equity:
17.06%
Return On Invested Capital:
10.86%
Operating Margin:
31.08%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $304.2M | $366.5M | $402.3M | $93M | $111.3M | |
| Gross Profit | $231.9M | $284.1M | $310M | $73M | $75.5M | |
| Operating Income | $101.1M | $161.3M | $167.9M | $43.2M | $34.6M | |
| EBITDA | $133.8M | $201.1M | $208M | $53.2M | $44.7M | |
| Diluted EPS | $0.44 | $0.69 | $1.39 | $0.02 | $1.08 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $236.9M | $454.6M | $305M | $400.6M | $684.6M | |
| Total Assets | $887.2M | $1.3B | $1.2B | $1.2B | $1.4B | |
| Current Liabilities | $3.1M | $163.9M | $36.2M | $223.8M | $48.5M | |
| Total Liabilities | $395.4M | $686.3M | $560.6M | $563.1M | $419.2M | |
| Total Equity | $491.8M | $641.4M | $627.5M | $668.5M | $1B | |
| Total Debt | $392.3M | $618.2M | $517.8M | $257.6M | $258.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $116.7M | $162.7M | $201.7M | $48.7M | $49.7M | |
| Cash From Investing | -$71.8M | -$53.5M | $1.4M | -$5.3M | $18.4M | |
| Cash From Financing | -$165.7M | -$28.6M | $12.8M | $211K | $10.8M | |
| Free Cash Flow | $116.4M | $162.3M | $196.5M | $48.4M | $48.6M | |
INVA
Sector
Market Cap
$1.8B
$25.8M
Price % of 52-Week High
98.54%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
1.87%
-1.67%
1-Year Price Total Return
31.23%
-21.92%
Beta (5-Year)
0.437
0.499
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$22.55
200-day SMA
Buy
Level
$19.76
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$21.14
Relative Strength Index (RSI14)
Buy
Level
80.65
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
-7.9007
50-day SMA
Buy
Level
$20.43
MACD (12, 26)
Buy
Level
0.89
25-day Aroon Oscillator
Buy
Level
96
On Balance Volume
Neutral
Level
--
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.9878)
Buy
CA Score
(Annual)
Level (0.3675)
Buy
Beneish M-Score
(Annual)
Level (-2.9963)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (3.3501)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.
Stock Forecast FAQ
In the current month, INVA has received 4 Buy ratings 0 Hold ratings, and 1 Sell ratings. The INVA average analyst price target in the past 3 months is $33.00.
-
Where Will Innoviva, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Innoviva, Inc. share price will rise to $33.00 per share over the next 12 months.
-
What Do Analysts Say About Innoviva, Inc.?
Analysts are divided on their view about Innoviva, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Innoviva, Inc. is a Sell and believe this share price will drop from its current level to $18.00.
-
What Is Innoviva, Inc.'s Price Target?
The price target for Innoviva, Inc. over the next 1-year time period is forecast to be $33.00 according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 1 rates the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is INVA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Innoviva, Inc. is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of INVA?
You can purchase shares of Innoviva, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Innoviva, Inc. shares.
-
What Is The Innoviva, Inc. Share Price Today?
Innoviva, Inc. was last trading at $23.62 per share. This represents the most recent stock quote for Innoviva, Inc.. Yesterday, Innoviva, Inc. closed at $23.66 per share.
-
How To Buy Innoviva, Inc. Stock Online?
In order to purchase Innoviva, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get INVA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
INVA
Sector
P/E ratio
16.97x
23.35x
PEG ratio
0.17x
-0.01x
P/B ratio
1.75x
1.78x
Price / LTM sales
4.65x
1.55x
Growth Metrics
INVA
Sector
Revenue growth
19.68%
3.74%
Earnings growth
5503.63%
11.14%
Revenue (5-year growth)
6.27%
6.38%
Earnings forecast
$0.43
-$0.19
Profitability
INVA
Sector
Profitability FY 2024
$296.1M
$2.6M
Return on invested capital
10.86%
-32.91%
Return on assets
9.67%
-29.56%
Return on equity
17.06%
-38.66%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Feb
4
Balance Sheet
INVA
Sector
Total cash
$533.1M
$25.2M
Short term investments
$107.5M
$24.1M
Total assets
$1.3B
$72.8M
Long term debt
$258.3M
$2.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
73
HYMC alert for Feb 19
Hycroft Mining Holding Corp. [HYMC] is up 3.81% over the past day.
Buy
57
GLBE alert for Feb 19
Global-e Online Ltd. [GLBE] is up 4.19% over the past day.
Sell
37
ACLS alert for Feb 20
Axcelis Technologies, Inc. [ACLS] is down 1.71% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
